Diabetes care division offering oral antidiabetics, DPP-4 inhibitors, SGLT-2 inhibitors and advanced combination therapies for better glycemic control.
| # | Image | Product Name | Composition |
|---|---|---|---|
| 1 |
|
GLIMESPAN M1 / GLIMERED M1 | Glimepiride 1 mg + Metformin 500 mg |
| 2 |
|
GLIMESPAN M2 / GLIMERED M2 | Glimepiride 2 mg + Metformin 500 mg |
| 3 |
|
VOGLISPAN M1 / VOGLIRED M1 | Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.2 mg |
| 4 |
|
VOGLISPAN M2 / VOGLIRED M2 | Glimepiride 2 mg + Metformin 500 mg + Voglibose 0.2 mg |
| 5 |
|
SITASPAN GM1 | Glimepiride 1 mg + Metformin 500 mg + Sitagliptin 50 mg |
| 6 |
|
SITASPAN GM2 | Glimepiride 2 mg + Metformin 500 mg + Sitagliptin 50 mg |
| 7 |
|
GLICLAZSPAD M80/500 | Gliclazide 80 mg + Metformin 500 mg |
| 8 |
|
DAPASPAN 10MG | Dapagliflozin 10 mg |
| 9 |
|
SITASPAN 100MG | Sitagliptin 100 mg Tablet |
| 10 |
|
SITASPAN D | Sitagliptin 100 mg + Dapagliflozin 10 mg |
| 11 |
|
SITASPAN DM | Sitagliptin 100 mg + Dapagliflozin 10 mg + Metformin 500 mg |
Get in touch with our team for pack sizes, availability, and partnership enquiries.
